Port-a-Cath® extravasation of vesicant cytotoxics: Surgical options for a rare complication of cancer chemotherapy

European Journal of Surgical Oncology

Volumn 41, Issue 3, 2015, Pages 378-385

  Haslik, W ^a   Hacker, S ^a   Felberbauer, F X ^a   Thallinger, C ^a   Bartsch, R ^a   Kornauth, C ^a   Deutschmann, C ^a   Mader, R M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Epirubicin; Extravasation; Port a Cath ; Procedure; Subcutaneous; Vesicant; Wash Out

Indexed keywords

CISPLATIN; EPIRUBICIN; OXALIPLATIN; PACLITAXEL; PLATINUM DERIVATIVE; TRABECTEDIN; 1,3 DIOXOLANE DERIVATIVE; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX; TETRAHYDROISOQUINOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLON CANCER; DEBRIDEMENT; DEVICE REMOVAL; ERYTHEMA; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMPLANTABLE PORT SYSTEM; INJECTION SITE EXTRAVASATION; INJECTION SITE INDURATION; LUNG CANCER; MALE; MIDDLE AGED; OVARY CANCER; PAIN; PRIORITY JOURNAL; RISK FACTOR; SARCOMA; SKIN REDNESS; TREATMENT OUTCOME; WOUND DRAIN; WOUND IRRIGATION; YOUNG ADULT; CENTRAL VENOUS CATHETER; DEVICE FAILURE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; LAVAGE; NEOPLASMS; PROCEDURES; SURGICAL FLAPS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BODY MASS INDEX; CISPLATIN; DEVICE REMOVAL; DIOXOLES; EPIRUBICIN; EQUIPMENT FAILURE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; RISK FACTORS; SURGICAL FLAPS; TETRAHYDROISOQUINOLINES; THERAPEUTIC IRRIGATION; VASCULAR ACCESS DEVICES; YOUNG ADULT;

EID: 84923043643     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.11.042     Document Type: Article

References (23)

1. T. Hamakawa, Y. Kojima, and T. Naiki Long-term survival of a patient with invasive signet-ring cell carcinoma of the urinary bladder managed by combined s-1 and Cisplatin adjuvant chemotherapy Case Rep Urol 2013 2013 915874
2. M. Futagami, Y. Yokoyama, and H. Mizunuma Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion Eur J Gynaecol Oncol 32 2011 99 102
3. J.P. Dutcher, and D. Nanus Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy Med Oncol 28 2011 1530 1533
4. M.O. Robinson, and P. Halverson Port-A-Cath: a study of complication rates S D J Med 44 1991 187 190
5. F.L. Greene, W. Moore, and G. Strickland Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac) South Med J 81 1988 580 583
6. L. Schulmeister, and D. Camp-Sorrell Chemotherapy extravasation from implanted ports Oncol Nurs Forum 27 2000 531 538 [quiz 9-40]
7. A.K. Bozkurt, B. Uzel, and C. Akman Intrathoracic extravasation of antineoplastic agents: case report and systematic review Am J Clin Oncol 26 2003 121 123
8. H.N. Langstein, H. Duman, and D. Seelig Retrospective study of the management of chemotherapeutic extravasation injury Ann Plast Surg 49 2002 369 374
9. C. Heibl, V. Trommet, and S. Burgstaller Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis Eur J Cancer Care 19 2010 676 681
10. S. Al-Benna, C. O'Boyle, and J. Holley Extravasation injuries in adults ISRN Dermatol 2013 2013 856541
11. C.M. Anderson, R.S. Walters, and G.N. Hortobagyi Mediastinitis related to probable central vinblastine extravasation in a woman undergoing adjuvant chemotherapy for early breast cancer Am J Clin Oncol 19 1996 566 568
12. M. de Wit, P. Ortner, and H.P. Lipp Management of cytotoxic extravasation - ASORS expert opinion for diagnosis, prevention and treatment Onkologie 36 2013 127 135
13. D.T. Gault Extravasation injuries Br J Plast Surg 46 1993 91 96
14. A. Steiert, U. Hille, and W. Burke Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations J Plast Reconstr Aesthetic Surg JPRAS 64 2011 240 247
15. L. Schulmeister Managing vesicant extravasations Oncol 13 2008 284 288
16. R.A. Ener, S.B. Meglathery, and M. Styler Extravasation of systemic hemato-oncological therapies Ann Oncol Off J Eur Soc Med Oncol ESMO 15 2004 858 862
17. S. Kurul, P. Saip, and T. Aydin Totally implantable venous-access ports: local problems and extravasation injury Lancet Oncol 3 2002 684 692
18. J.A. Perez Fidalgo, L. Garcia Fabregat, and A. Cervantes Management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines Ann Oncol Off J Eur Soc Med Oncol ESMO 23 Suppl. 7 2012 vii167 vii173
19. J.G. Choi, J.S. Choi, and C.H. Park Hydrothorax due to extravasation of intravenous contrast through left subclavian catheter - a case report Korean J Anesthesiol 58 2010 550 554
20. J.M. Rodier, L. Malbec, and E.P. Lauraine Mediastinal infusion of epirubicin and 5-fluorouracil. A complication of totally implantable central venous systems. Report of a case J Cancer Res Clin Oncol 122 1996 566 567
21. K. Harrold, D. Gould, and N. Drey The efficacy of saline washout technique in the management of exfoliant and vesicant chemotherapy extravasation: a historical case series report Eur J Cancer Care 22 2013 169 178
22. A. Surov, K. Jordan, and M. Buerke Port catheter insufficiency: incidence and clinical-radiological correlations Onkologie 31 2008 455 461
23. A. Banerjee, T.M. Brotherston, and B.G. Lamberty Cancer chemotherapy agent-induced perivenous extravasation injuries Postgrad Med J 63 1987 5 9